Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Dolphimed A/S
A/S
Active
Advertising protection
CVR 42539023
Pilestræde 58, 1112
København K
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 4 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Dolphimed A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
-15M
2022
-2M
2023
0M
2024
EBITDA
DKK millions
0M
-5M
-11M
-16M
-21M
-17M
2022
-2M
+88%
2023
0M
+100%
2024
Income statement
DKK thousands
Item
2022
2023
2024
Gross profit
-15.469
-1.932
-163
Staff expenses
-1.057
-1
-0
EBITDA
-16.525
-1.933
-163
Depreciation & amort.
-463
-694
-694
EBIT
-16.988
-2.627
-858
Net financials
-3.143
-3.808
-4.311
Profit before tax
-20.131
-6.435
-5.169
Tax
-0
-0
-0
Net profit
-20.131
-6.435
-5.169
Balance sheet
DKK thousands
Item
2022
2023
2024
Total assets
23.179
16.994
16.106
Equity
-19.731
-26.166
-31.335
Long-term debt
39.207
43.127
47.440
Short-term debt
3.703
33
0
Total debt
42.910
43.160
47.440
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-16337300.0%
This company
2022
2024
Equity ratio
-194.6%
This company
38.2%
Market median
-609% vs market
2022
2024
Return on equity
-516894700.0%
This company
18.4%
Market median
-2809210426% vs market
2022
2024
Net profit margin (of gross profit)
-516894700.0%
This company
2022
2024
Asset turnover (of gross profit)
-0.01×
This company
2022
2024
Debt / equity
1.51×
This company
0.62×
Market median
-144% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-07-01 – 2022-12-31
View
PDF
More on Dolphimed A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network